Rockwell Medical, Inc. (RMTI)
USD 1.23
(13.89%)
USD 1.23
(13.89%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.29 Million USD | -32.16% |
| 2022 | 12.22 Million USD | -35.91% |
| 2021 | 19.07 Million USD | -16.24% |
| 2020 | 22.77 Million USD | 1178.76% |
| 2019 | 1.78 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 17.91 Million USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 2280.00 USD | -73.94% |
| 2010 | 8750.00 USD | -54.1% |
| 2009 | 19.06 Thousand USD | -53.74% |
| 2008 | 41.2 Thousand USD | -79.88% |
| 2007 | 204.83 Thousand USD | -37.18% |
| 2006 | 326.04 Thousand USD | -55.56% |
| 2005 | 733.72 Thousand USD | -10.38% |
| 2004 | 818.67 Thousand USD | -11.61% |
| 2003 | 926.23 Thousand USD | 18.52% |
| 2002 | 781.5 Thousand USD | -12.44% |
| 2001 | 892.54 Thousand USD | 4398.93% |
| 2000 | 19.83 Thousand USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 8.26 Million USD | -0.34% |
| 2024 Q2 | 8.29 Million USD | 0.36% |
| 2023 Q3 | 6.67 Million USD | 74.25% |
| 2023 FY | 8.29 Million USD | -32.16% |
| 2023 Q2 | 3.83 Million USD | -62.83% |
| 2023 Q1 | 10.31 Million USD | -15.65% |
| 2023 Q4 | 8.29 Million USD | 24.17% |
| 2022 FY | 12.22 Million USD | -35.91% |
| 2022 Q3 | 14.13 Million USD | -7.73% |
| 2022 Q1 | 17.17 Million USD | -9.94% |
| 2022 Q2 | 15.31 Million USD | -10.83% |
| 2022 Q4 | 12.22 Million USD | -13.51% |
| 2021 Q1 | 24.56 Million USD | 7.87% |
| 2021 FY | 19.07 Million USD | -16.24% |
| 2021 Q2 | 4.5 Million USD | -81.66% |
| 2021 Q4 | 19.07 Million USD | -1.28% |
| 2021 Q3 | 19.32 Million USD | 328.76% |
| 2020 Q4 | 22.77 Million USD | 4.0% |
| 2020 Q1 | 22.24 Million USD | 1149.19% |
| 2020 Q2 | 21.96 Million USD | -1.24% |
| 2020 Q3 | 21.89 Million USD | -0.33% |
| 2020 FY | 22.77 Million USD | 1178.76% |
| 2019 FY | 1.78 Million USD | 0.0% |
| 2019 Q3 | 1.58 Million USD | -5.99% |
| 2019 Q2 | 1.69 Million USD | 26.49% |
| 2019 Q4 | 1.78 Million USD | 12.05% |
| 2019 Q1 | 1.33 Million USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q1 | 16.22 Million USD | -9.45% |
| 2014 Q2 | 14.48 Million USD | -10.75% |
| 2014 Q3 | 12.05 Million USD | -16.77% |
| 2014 FY | - USD | -100.0% |
| 2014 Q4 | - USD | -100.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | 17.91 Million USD | -7.78% |
| 2013 Q3 | 19.42 Million USD | -2.86% |
| 2013 FY | 17.91 Million USD | 0.0% |
| 2013 Q2 | 20 Million USD | 0.0% |
| 2012 Q1 | 1451.00 USD | -36.36% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q2 | 591.00 USD | -59.27% |
| 2012 FY | - USD | -100.0% |
| 2011 FY | 2280.00 USD | -73.94% |
| 2011 Q4 | 2280.00 USD | -25.93% |
| 2011 Q3 | 3078.00 USD | -25.36% |
| 2011 Q2 | 4124.00 USD | -27.43% |
| 2011 Q1 | 5683.00 USD | -35.05% |
| 2010 FY | 8750.00 USD | -54.1% |
| 2010 Q2 | 9365.00 USD | -80.46% |
| 2010 Q1 | 47.93 Thousand USD | 151.48% |
| 2010 Q3 | 11.74 Thousand USD | 25.36% |
| 2010 Q4 | 8750.00 USD | -25.47% |
| 2009 Q3 | 26.46 Thousand USD | -11.66% |
| 2009 Q1 | 28.97 Thousand USD | -29.68% |
| 2009 Q2 | 29.95 Thousand USD | 3.39% |
| 2009 Q4 | 19.06 Thousand USD | -27.97% |
| 2009 FY | 19.06 Thousand USD | -53.74% |
| 2008 FY | 41.2 Thousand USD | -79.88% |
| 2008 Q1 | 149.26 Thousand USD | -27.13% |
| 2008 Q3 | 58.19 Thousand USD | -42.65% |
| 2008 Q4 | 41.2 Thousand USD | -29.19% |
| 2008 Q2 | 101.46 Thousand USD | -32.02% |
| 2007 Q3 | 240.73 Thousand USD | -11.44% |
| 2007 FY | 204.83 Thousand USD | -37.18% |
| 2007 Q1 | 315.74 Thousand USD | -3.16% |
| 2007 Q2 | 271.84 Thousand USD | -13.91% |
| 2007 Q4 | 204.83 Thousand USD | -14.91% |
| 2006 Q3 | 414.63 Thousand USD | -6.45% |
| 2006 Q4 | 326.04 Thousand USD | -21.37% |
| 2006 Q1 | 606.85 Thousand USD | -17.29% |
| 2006 Q2 | 443.22 Thousand USD | -26.96% |
| 2006 FY | 326.04 Thousand USD | -55.56% |
| 2005 Q3 | 566.05 Thousand USD | -12.06% |
| 2005 Q2 | 643.65 Thousand USD | -14.25% |
| 2005 FY | 733.72 Thousand USD | -10.38% |
| 2005 Q1 | 750.65 Thousand USD | -8.31% |
| 2005 Q4 | 733.72 Thousand USD | 29.62% |
| 2004 Q4 | 818.67 Thousand USD | -4.62% |
| 2004 Q1 | 1.01 Million USD | 9.47% |
| 2004 Q2 | 913.98 Thousand USD | -9.86% |
| 2004 Q3 | 858.29 Thousand USD | -6.09% |
| 2004 FY | 818.67 Thousand USD | -11.61% |
| 2003 FY | 926.23 Thousand USD | 18.52% |
| 2003 Q1 | 712.74 Thousand USD | -8.8% |
| 2003 Q3 | 631.15 Thousand USD | -7.76% |
| 2003 Q2 | 684.22 Thousand USD | -4.0% |
| 2003 Q4 | 926.23 Thousand USD | 46.75% |
| 2002 Q1 | 886.36 Thousand USD | -0.69% |
| 2002 Q3 | - USD | -100.0% |
| 2002 Q4 | 781.5 Thousand USD | 0.0% |
| 2002 Q2 | 834.57 Thousand USD | -5.84% |
| 2002 FY | 781.5 Thousand USD | -12.44% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q1 | 114.41 Thousand USD | 476.74% |
| 2001 FY | 892.54 Thousand USD | 4398.93% |
| 2001 Q4 | 892.54 Thousand USD | 0.0% |
| 2001 Q2 | 80.65 Thousand USD | -29.51% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | 19.83 Thousand USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | 19.83 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 501.54 Million USD | 98.347% |
| Theratechnologies Inc. | 51.26 Million USD | 83.822% |
| Safety Shot Inc | 304.9 Thousand USD | -2619.845% |
| Cosmos Health Inc. | 3.03 Million USD | -173.215% |
| Cronos Group Inc. | 1.55 Million USD | -431.943% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 98.336% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 75.744% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 86.348% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 19.156% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -9432.183% |
| Dynavax Technologies Corporation | 252.41 Million USD | 96.715% |
| Radius Health, Inc. | 339.66 Million USD | 97.558% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -6980.227% |
| Alvotech | 1.02 Billion USD | 99.193% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1438.49% |
| Alpha Teknova, Inc. | 13.25 Million USD | 37.416% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 37.768% |
| SCYNEXIS, Inc. | 12.15 Million USD | 31.795% |
| Harrow Health, Inc. | 183.17 Million USD | 95.473% |
| Biofrontera Inc. | 804 Thousand USD | -931.468% |
| DURECT Corporation | 2.7 Million USD | -206.921% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 75.018% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 97.322% |
| OptiNose, Inc. | 611 Thousand USD | -1257.283% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -1722.637% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 90.894% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 35.131% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -2368.221% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 93.118% |
| Shineco, Inc. | 10.01 Million USD | 17.213% |
| Phibro Animal Health Corporation | 458.28 Million USD | 98.19% |
| Procaps Group S.A. | 28.41 Million USD | 70.81% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -26.96% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Viatris Inc. | 16.18 Billion USD | 99.949% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -1438.49% |
| Incannex Healthcare Limited | 210 Thousand USD | -3849.047% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 23.757% |
| Tilray Brands, Inc. | 287.93 Million USD | 97.12% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 98.307% |
| PetIQ, Inc. | 437.82 Million USD | 98.106% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 96.789% |
| Journey Medical Corporation | 14.62 Million USD | 43.284% |
| Alimera Sciences, Inc. | 64.48 Million USD | 87.14% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -20.936% |
| Assertio Holdings, Inc. | 38.51 Million USD | 78.468% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -6038.915% |
| Embecta Corp. | 1.62 Billion USD | 99.49% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -36784.002% |
| Procaps Group, S.A. | 28.41 Million USD | 70.81% |
| PainReform Ltd. | 30 Thousand USD | -27543.33% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 74.686% |
| Hempacco Co., Inc. | 5.93 Million USD | -39.825% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 98.386% |
| Alvotech | 1.02 Billion USD | 99.193% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 98.654% |
| Kamada Ltd. | 7.43 Million USD | -11.495% |
| Indivior PLC | 235.66 Million USD | 96.481% |
| Currenc Group, Inc. | 2.5 Million USD | -230.797% |
| Evoke Pharma, Inc. | 5 Million USD | -65.86% |
| Flora Growth Corp. | 942 Thousand USD | -780.361% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -36784.002% |
| Evolus, Inc. | 120.35 Million USD | 93.11% |
| HUTCHMED (China) Limited | 48.18 Million USD | 82.791% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 98.592% |
| Akanda Corp. | 2.49 Million USD | -232.098% |